Patents, Trade Marks, Designs, Copyrights, IP Solicitors, Appeals and Oppositions, Due Diligence and Strategy.

HGF offers everything you would expect of a world-class intellectual property firm, including patent and trade mark acquisition as well as appeals and oppositions to protect your creative work.

We also focus on providing a bespoke service tailored to your industry, to ensure you really get the most out of your big ideas. Our teams are dedicated to providing professional, expert advice and support every step of the way.

The latest news and cutting edge commentary from across the group

October 2017
October 2017

Get a taste of IP and grow your food and drink business

If you have a business operating in the food and drink sector, or are thinking of starting one, this free half-day event is for you.

Find out more
October 2017

HGF Birmingham go straight in at Tier 2 in The Legal 500

The HGF Birmingham office have been ranked for the first time in the West Midlands and have immediately been positioned at Tier 2 in The Legal 500, with Marie McMorrow (Partner and IP Solicitor) listed as a leading individual and Tom Nener (Legal Director and IP Solicitor) listed as a next…

HGF Birmingham go straight in at Tier 2 in The Legal 500 Find out more
October 2017

Use of Images of Registered Community Designs – Nintendo v BigBen

The CJEU has ruled (Nintendo Co. Ltd v BigBen Interactive GmbH, BigBen Interactive SA, C‑24/16 and C‑25/16)that third parties may use images of goods protected by registered community designs for certain specific commercial purposes, delivering a setback to design rights owners. In this ca…

Use of Images of Registered Community Designs – Nintendo v BigBen Find out more
October 2017

Changes to IP Law from 1 October 2017

On 1 October 2017 a number of reforms to IP law came into force.

Changes to IP Law from 1 October 2017 Find out more
September 2017
September 2017

EU trade mark regulation changes applying 1 October 2017

Last March, the new EU trade mark regulation brought a number of changes to trade mark practice at the EUIPO into being. The Amending Regulation also contained a number of provisions that would come into force only 21 months after its publication, as they had to be developed by secondary …

 EU trade mark regulation changes applying 1 October 2017 Find out more
September 2017

Oxford Bacteriophage Conference 2017

HGF Partner Craig Thomson will be Co-presenting "Creating Impact: The challenges and opportunities of commercialisation in the field of bacteriophage research" alongside Professor Martha RJ Clokie.

Find out more
September 2017

EU Commission Paper on IP and Brexit

The European Commission Brexit Task Force has published its Position Paper on IP rights and Brexit.

EU Commission Paper on IP and Brexit Find out more
September 2017

UK Registered Designs: displaying your rights using webmarking from 1 October 2017

Showing the world the registered design protection you have for your products in the UK will get easier from 1 October 2017; from this date you will have the option of marking your product with a web address which associates the product with a UK registered design number(s).

UK Registered Designs: displaying your rights using webmarking from 1 October 2017 Find out more
September 2017

HGF is listed 2nd in the top 100 trade mark filers of both UK & EU applications 2016 in CITMA Review.

HGF, one of Europe's leading IP firms, is listed 2nd in the top 100 trade mark filers for both EU & UK filings.

HGF is listed 2nd in the top 100 trade mark filers of both UK & EU applications 2016 in CITMA Review. Find out more
September 2017

IP in Retail Conference 2017

IP in Retail 2017 - HGF's fifth annual conference will be held in September in Leeds and London. The conference addresses topical IP issues for retailers.

Find out more
August 2017
August 2017

EMA Concept Paper - Interface between Companion Diagnostics and Medicines Development

Personalised medicine aims to tailor treatments to individual patients based on their predicted response or risk of disease. It can avoid unnecessary treatment, improve drug-development success rates and reduce costs. Biomarker-based assays have become key tools in the personalised medicin…

EMA Concept Paper - Interface between Companion Diagnostics and Medicines Development Find out more
August 2017

Plausibility at the EPO - Decision T 0488/16 Dasatinib/BRISTOL-MYERS SQUIB

An inventive step requiring particular technical effect or solving a particular problem must have a plausible disclosure of having achieved that in the original specification.

Plausibility at the EPO - Decision T 0488/16 Dasatinib/BRISTOL-MYERS SQUIB Find out more